Naphthoquinones: Atovaquone, and other antimalarials targeting mitochondrial functions

Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use

Volumn , Issue , 2012, Pages 127-139

  Vaidya, Akhil B ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928889538     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-0346-0480-2_7     Document Type: Chapter

References (52)

1. Vaidya AB, Lashgari MS, Pologe LG, Morrisey J (1993) Structural features of Plasmodium cytochrome b that may underlie susceptibility to 8-aminoquinolines and hydroxynaphthoquinones. Mol Biochem Parasitol 58:33-42
2. Vaidya AB, Mather MW (2009) Mitochondrial evolution and functions in malaria parasites. Annu Rev Microbiol 63:249-267
3. Foth BJ, Stimmler LM, Handman E, Crabb BS, Hodder AN, McFadden GI (2005) The malaria parasite Plasmodium falciparum has only one pyruvate dehydrogenase complex, which is located in the apicoplast. Mol Microbiol 55:39-53
4. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S et al (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498-511
5. Fisher N, Bray PG, Ward SA, Biagini GA (2007) The malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyle. Trends Parasitol 23:305-310
6. Crofts AR (2004) The cytochrome bc1 complex: function in the context of structure. Annu Rev Physiol 66:689-733
7. Cooley JW (2010) A structural model for across membrane coupling between the Qo and Qi active sites of cytochrome bc1. Biochim Biophys Acta 1797:1842-1848
8. Mather MW, Darrouzet E, Valkova-Valchanova M, Cooley JW, McIntosh MT, Daldal F, Vaidya AB (2005) Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system. J Biol Chem 280:27458-27465
9. Srivastava IK, Morrisey JM, Darrouzet E, Daldal F, Vaidya AB (1999) Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol Microbiol 33:704-711
10. Kessl JJ, Lange BB, Merbitz-Zahradnik T, Zwicker K, Hill P, Meunier B, Palsdottir H, Hunte C, Meshnick S, Trumpower BL (2003) Molecular basis for atovaquone binding to the cytochrome bc1 complex. J Biol Chem 278:31312-31318
11. Kessl JJ, Meshnick SR, Trumpower BL (2007) Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi. Trends Parasitol 23:494-501
12. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ (1996) Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54:62-66
13. Rathod PK, McErlean T, Lee PC (1997) Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94:9389-9393
14. McIntosh MT, Srivastava R, Vaidya AB (1998) Divergent evolutionary constraints on mitochondrial and nuclear genomes of malaria parasites. Mol Biochem Parasitol 95:69-80
15. Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White NJ, Suh E et al (2003) Early origin and recent expansion of Plasmodium falciparum. Science 300:318-321
16. Vaidya AB, Arasu P (1987) Tandemly arranged gene clusters of malarial parasites that are highly conserved and transcribed. Mol Biochem Parasitol 22:249-257
17. Preiser PR, Wilson RJ, Moore PW, McCready S, Hajibagheri MA, Blight KJ, Strath M, Williamson DH (1996) Recombination associated with replication of malarial mitochondrial DNA. EMBO J 15:684-693
18. Canfield CJ, Pudney M, Gutteridge WE (1995) Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol 80:373-381
19. Carrington HC, Crowther AF, Davey DG, Levi AA, Rose FL (1951) A metabolite of "Paludrine" with high antimalarial activity. Nature 168:1080
20. Crowther AF, Levi AA (1953) Proguanil - the isolation of a metabolite with high antimalarial activity. Br J Pharmacol 8:93-97
21. Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB (1999) Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg 60:533-541
22. Fivelman QL, Butcher GA, Adagu IS, Warhurst DC, Pasvol G (2002) Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar J 1:1
23. Kuhn S, Gill MJ, Kain KC (2005) Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa. Am J Trop Med Hyg 72:407-409
24. Krudsood S, Patel SN, Tangpukdee N, Thanachartwet W, Leowattana W, Pornpininworakij K, Boggild AK, Looareesuwan S, Kain KC (2007) Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 76:655-658
25. Srivastava IK, Rottenberg H, Vaidya AB (1997) Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J Biol Chem 272:3961-3966
26. Srivastava IK, Vaidya AB (1999) A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob Agents Chemother 43:1334-1339
27. Nyakeriga AM, Perlmann H, Hagstedt M, Berzins K, Troye-Blomberg M, Zhivotovsky B, Perlmann P, Grandien A (2006) Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs without typical signs of apoptosis. Microbes Infect 8:1560-1568
28. Painter HJ, Morrisey JM, Vaidya AB (2010) Mitochondrial electron transport inhibition and viability of intraerythrocytic Plasmodium falciparum. Antimicrob Agents Chemother 54:5281-5287
29. Nagy M, Lacroute F, Thomas D (1992) Divergent evolution of pyrimidine biosynthesis between anaerobic and aerobic yeasts. Proc Natl Acad Sci USA 89:8966-8970
30. Painter HJ, Morrisey JM, Mather MW, Vaidya AB (2007) Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. Nature 446:88-91
31. Ganesan SM, Morrisey JM, Ke H, Painter HJ, Laroiya K, Phillips MA, Rathod PK, Mather MW, Vaidya AB (2011) Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection. Mol Biochem Parasitol 177:29-34
32. Phillips MA, Gujjar R, Malmquist NA, White J, El Mazouni F, Baldwin J, Rathod PK (2008) Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum. J Med Chem 51:3649-3653
33. Fidock DA, Nomura T, Wellems TE (1998) Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. Mol Pharmacol 54:1140-1147
34. Helsby NA, Ward SA, Howells RE, Breckenridge AM (1990) In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme. Br J Clin Pharmacol 30:287-291
35. Herrlin K, Massele AY, Jande M, Alm C, Tybring G, Abdi YA, Wennerholm A, Johansson I, Dahl ML, Bertilsson L et al (1998) Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype. Clin Pharmacol Ther 64:391-401
36. Wanwimolruk S, Bhawan S, Coville PF, Chalcroft SC (1998) Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations. Eur J Clin Pharmacol 54:431-435
37. Xie HG, Kim RB, Stein CM, Wilkinson GR, Wood AJ (1999) Genetic polymorphism of (S)-mephenytoin 40-hydroxylation in populations of African descent. Br J Clin Pharmacol 48:402-408
38. Desta Z, Zhao X, Shin JG, Flockhart DA (2002) Clinical significance of the cytochrome P450 2 C19 genetic polymorphism. Clin Pharmacokinet 41:913-958
39. Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F et al (2010) Chemical genetics of Plasmodium falciparum. Nature 465:311-315
40. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S et al (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465:305-310
41. Yeates CL, Batchelor JF, Capon EC, Cheesman NJ, Fry M, Hudson AT, Pudney M, Trimming H, Woolven J, Bueno JM et al (2008) Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials. J Med Chem 51:2845-2852
42. Winter RW, Kelly JX, Smilkstein MJ, Dodean R, Hinrichs D, Riscoe MK (2008) Antimalarial quinolones: synthesis, potency, and mechanistic studies. Exp Parasitol 118:487-497
43. Winter R, Kelly JX, Smilkstein MJ, Hinrichs D, Koop DR, Riscoe MK (2011) Optimization of endochin-like quinolones for antimalarial activity. Exp Parasitol 127(2):545-51
44. Winter RW, Kelly JX, Smilkstein MJ, Dodean R, Bagby GC, Rathbun RK, Levin JI, Hinrichs D, Riscoe MK (2006) Evaluation and lead optimization of anti-malarial acridones. Exp Parasitol 114:47-56
45. Biagini GA, Fisher N, Berry N, Stocks PA, Meunier B, Williams DP, Bonar-Law R, Bray PG, Owen A, O'Neill PM et al (2008) Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex. Mol Pharmacol 73:1347-1355
46. Li W, Mo W, Shen D, Sun L, Wang J, Lu S, Gitschier JM, Zhou B (2005) Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet 1:e36
47. Wang J, Huang L, Li J, Fan Q, Long Y, Li Y, Zhou B (2010) Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation. PLoS One 5:e9582
48. Phillips MA, Rathod PK (2010) Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy. Infect Disord Drug Targets 10:226-239
49. Booker ML, Bastos CM, Kramer ML, Barker RH Jr, Skerlj R, Sidhu AB, Deng X, Celatka C, Cortese JF, Guerrero Bravo JE et al (2010) Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model. J Biol Chem 285:33054-33064
50. Mather MW, Henry KW, Vaidya AB (2007) Mitochondrial drug targets in apicomplexan parasites. Curr Drug Targets 8:49-60
51. Olszewski KL, Mather MW, Morrisey JM, Garcia BA, Vaidya AB, Rabinowitz JD, Llinas M (2010) Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature 466:774-778
52. Balabaskaran Nina P, Dudkina NV, Kane LA, van Eyk JE, Boekema EJ, Mather MW, Vaidya AB (2010) Highly divergent mitochondrial ATP synthase complexes in Tetrahymena thermophila. PLoS Biol 8:e1000418